• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T1期高级别膀胱癌患者行部分膀胱切除术与经尿道膀胱肿瘤切除术的生存结果:一项倾向评分匹配研究

Survival Outcome of Partial Cystectomy versus Transurethral Bladder Tumor Resection in T1 High-Grade Bladder Cancer Patients: A Propensity Score Matching Study.

作者信息

Ping Zheng, Zhan Xiangpeng, Chen Tao, Zheng Yunwei, Jiang Ming, Li Yu, Fu Bin

机构信息

Department of Urology, Shangrao Municipal Hospital, Shangrao, Jiangxi, China.

Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

出版信息

J Oncol. 2022 Oct 25;2022:3016725. doi: 10.1155/2022/3016725. eCollection 2022.

DOI:10.1155/2022/3016725
PMID:36330353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9626196/
Abstract

PURPOSE

Partial cystectomy was investigated as a method of bladder preservation with better disease outcomes than transurethral bladder tumor resection in T1 high-grade bladder cancer patients. . The national Surveillance, Epidemiology, and End Results database (SEER) (2004-2015) were used to obtain patients diagnosed with T1 high-grade bladder cancer, and finally, 25263 patients were enrolled in our study. The Kaplan-Meier method with the log-rank test was performed to analyze the outcome of overall survival (OS) and cancer-specific survival (CSS) between patients undergoing partial cystectomy (PC), transurethral resection of bladder tumor (TURBT), or radical cystectomy (RC). Moreover, the propensity score matching (PSM) and multivariable Cox proportional hazard model were also utilized in the study.

RESULTS

Ultimately, 24635 patients were undergoing TURBT, while 190 and 438 patients were, respectively, assigned to the PC and RC groups. Compared with patients with TURBT, a tendency of a higher proportion of higher older and male patients was observed in the PC group. When matching with RC patients, patients in the PC group were commonly older and had bigger tumor sizes and single tumors (All < 0.05). After 1 : 1 PSM, 190 patients with TURBT and 160 patients receiving PC were selected. In survival analysis, the patients in the PC group had a higher survival probability of both OS and CSS before and after PSM compared with those in the TURBT group. Meanwhile, no significant differences were observed between the RC and PC groups in OS and CSS analysis. Moreover, multivariable Cox regression showed that PC was a protective factor for overall mortality (ACM) and cancer-specific mortality (CSM) compared with TURBT in T1 high-grade patients (All < 0.05).

CONCLUSION

Patients undergoing partial cystectomy were shown to have a better outcome compared with those with transurethral bladder tumor resection in T1 high-grade bladder cancer patients. Partial cystectomy could be the more worthwhile choice for bladder preservation in T1 high-grade bladder cancer patients.

摘要

目的

研究部分膀胱切除术作为一种膀胱保留方法,在T1期高级别膀胱癌患者中是否比经尿道膀胱肿瘤切除术具有更好的疾病预后。使用国家监测、流行病学和最终结果数据库(SEER)(2004 - 2015年)获取诊断为T1期高级别膀胱癌的患者,最终25263例患者纳入本研究。采用Kaplan - Meier法和对数秩检验分析接受部分膀胱切除术(PC)、经尿道膀胱肿瘤切除术(TURBT)或根治性膀胱切除术(RC)患者的总生存期(OS)和癌症特异性生存期(CSS)结局。此外,研究还采用了倾向评分匹配(PSM)和多变量Cox比例风险模型。

结果

最终,24635例患者接受了TURBT,190例和438例患者分别被分配到PC组和RC组。与TURBT患者相比,PC组中年龄较大和男性患者的比例有更高的趋势。与RC患者匹配时,PC组患者通常年龄较大,肿瘤体积更大且为单发肿瘤(均P<0.05)。经过1:1 PSM后,选择了190例TURBT患者和160例接受PC的患者。在生存分析中,PSM前后PC组患者的OS和CSS生存概率均高于TURBT组患者。同时,在OS和CSS分析中,RC组和PC组之间未观察到显著差异。此外,多变量Cox回归显示,在T1期高级别患者中,与TURBT相比,PC是总死亡率(ACM)和癌症特异性死亡率(CSM)的保护因素(均P<0.05)。

结论

在T1期高级别膀胱癌患者中,接受部分膀胱切除术的患者与经尿道膀胱肿瘤切除术的患者相比,预后更好。部分膀胱切除术可能是T1期高级别膀胱癌患者膀胱保留更值得选择的方法。

相似文献

1
Survival Outcome of Partial Cystectomy versus Transurethral Bladder Tumor Resection in T1 High-Grade Bladder Cancer Patients: A Propensity Score Matching Study.T1期高级别膀胱癌患者行部分膀胱切除术与经尿道膀胱肿瘤切除术的生存结果:一项倾向评分匹配研究
J Oncol. 2022 Oct 25;2022:3016725. doi: 10.1155/2022/3016725. eCollection 2022.
2
Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.在经尿道膀胱肿瘤切除术再分期时,对于残余 T1 膀胱癌患者,即刻根治性膀胱切除术的作用。
BJU Int. 2013 Jul;112(1):54-9. doi: 10.1111/j.1464-410X.2012.11391.x. Epub 2012 Nov 13.
3
The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registries.肿瘤位置对行经尿道膀胱肿瘤切除术的非肌层浸润性膀胱癌患者预后的影响:利用中国多中心和 SEER 登记处的队列研究得出的见解。
Int J Surg. 2024 Sep 1;110(9):5641-5651. doi: 10.1097/JS9.0000000000001675.
4
Prognostic significance of bladder neck involvement in non-muscle-invasive bladder cancer: A SEER database analysis with 19,919 patients.膀胱癌膀胱颈部侵犯的预后意义:基于 19919 例患者的 SEER 数据库分析。
Cancer Med. 2021 Oct;10(19):6868-6880. doi: 10.1002/cam4.4219. Epub 2021 Aug 23.
5
Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients.80 岁以上肌层浸润性膀胱癌患者行根治性膀胱切除术或经尿道膀胱肿瘤切除术的临床疗效和生活质量:143 例回顾性分析。
Int Urol Nephrol. 2022 Jan;54(1):71-79. doi: 10.1007/s11255-021-03073-5. Epub 2021 Nov 24.
6
Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.膀胱憩室内尿路上皮癌:特征与临床结局的多中心分析
Eur Urol Focus. 2020 Nov 15;6(6):1226-1232. doi: 10.1016/j.euf.2018.12.002. Epub 2018 Dec 14.
7
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.光动力诊断辅助经尿道膀胱肿瘤切除术对根治性膀胱切除术后预后结果的影响:来自2011年PROMETRICS研究的结果
World J Urol. 2017 Feb;35(2):245-250. doi: 10.1007/s00345-016-1877-4. Epub 2016 Jun 14.
8
The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis.T1 非肌肉浸润性膀胱癌经尿道膀胱肿瘤电切术再分期对生存参数的影响:系统评价和荟萃分析。
J Endourol. 2020 Aug;34(8):795-804. doi: 10.1089/end.2020.0301. Epub 2020 Jun 3.
9
Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study.在美国,经尿道膀胱肿瘤切除术与根治性膀胱切除术治疗浸润性膀胱癌的流行率和结局:一项基于人群的队列研究。
Int J Surg. 2022 Jul;103:106693. doi: 10.1016/j.ijsu.2022.106693. Epub 2022 Jun 9.
10
Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.在保留膀胱的治疗方法中,接受诱导放化疗后疾病持续存在而行膀胱切除术的肌层浸润性膀胱癌患者,基于病理学的风险分层。
BJU Int. 2012 Sep;110(6 Pt B):E203-8. doi: 10.1111/j.1464-410X.2011.10874.x. Epub 2012 Jan 30.

引用本文的文献

1
Comparison of neoadjuvant chemotherapy and combined chemotherapy with immunotherapy for muscle-invasive bladder cancer: a propensity score-matched analysis.新辅助化疗与免疫疗法联合化疗治疗肌层浸润性膀胱癌的比较:倾向评分匹配分析
Am J Transl Res. 2025 Jan 15;17(1):125-143. doi: 10.62347/IOZU2458. eCollection 2025.
2
Impact of multi-parameter images obtained from dual-energy CT on radiomics to predict pathological grading of bladder urothelial carcinoma.基于双能 CT 多参数图像的影像组学对预测膀胱尿路上皮癌病理分级的价值。
Abdom Radiol (NY). 2024 Dec;49(12):4324-4333. doi: 10.1007/s00261-024-04516-0. Epub 2024 Aug 12.
3

本文引用的文献

1
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis.年龄对膀胱单纯原位癌患者结局的影响:多机构队列分析。
Clin Genitourin Cancer. 2022 Apr;20(2):e166-e172. doi: 10.1016/j.clgc.2021.12.005. Epub 2021 Dec 10.
2
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis.2019冠状病毒病大流行对高危非肌层浸润性膀胱癌患者初次、二次切除及辅助膀胱内治疗时间的影响:一项回顾性多机构队列分析
Cancers (Basel). 2021 Oct 21;13(21):5276. doi: 10.3390/cancers13215276.
3
expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype.
作为 T1 高级膀胱癌风险分层的潜在预后生物标志物的表达:揭示一种独特的非肌肉浸润亚型的侵袭性本质。
Investig Clin Urol. 2024 Jan;65(1):94-103. doi: 10.4111/icu.20230227.
4
CT-based deep learning radiomics nomogram for the prediction of pathological grade in bladder cancer: a multicenter study.基于 CT 的深度学习放射组学列线图预测膀胱癌病理分级:多中心研究。
Cancer Imaging. 2023 Sep 18;23(1):89. doi: 10.1186/s40644-023-00609-z.
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer.
全身综合炎症评分(SCIS):一种预测高危非肌层浸润性尿路上皮膀胱癌患者肿瘤学结局的新评分。
Transl Androl Urol. 2021 Feb;10(2):626-635. doi: 10.21037/tau-20-1272.
4
Partial cystectomy for muscle-invasive bladder cancer: a review of the literature.肌肉浸润性膀胱癌的部分膀胱切除术:文献综述
Transl Androl Urol. 2020 Dec;9(6):2938-2945. doi: 10.21037/tau.2020.03.04.
5
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study.他汀类药物的使用与首次诊断为 T1 高级别非肌肉浸润性膀胱尿路上皮癌患者的肿瘤学结局的关联:来自一项多中心研究的结果。
Minerva Urol Nephrol. 2021 Dec;73(6):796-802. doi: 10.23736/S2724-6051.20.04076-X. Epub 2021 Jan 13.
6
Stage T1 bladder cancer: diagnostic criteria and pitfalls.T1 期膀胱癌:诊断标准和误区。
Pathology. 2021 Jan;53(1):67-85. doi: 10.1016/j.pathol.2020.09.014. Epub 2020 Nov 3.
7
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.欧洲泌尿外科学会非肌肉浸润性膀胱癌(TaT1 和原位癌)指南 - 2019 年更新版。
Eur Urol. 2019 Nov;76(5):639-657. doi: 10.1016/j.eururo.2019.08.016. Epub 2019 Aug 20.
8
Organ preservation in bladder cancer: an opportunity for truly personalized treatment.膀胱癌的保器官治疗:实现真正个体化治疗的机会。
Nat Rev Urol. 2019 Sep;16(9):511-522. doi: 10.1038/s41585-019-0199-x. Epub 2019 Jun 13.
9
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.高危非肌肉浸润性膀胱癌患者的系统性炎症标志物与肿瘤学结局。
Eur Urol Oncol. 2018 Oct;1(5):403-410. doi: 10.1016/j.euo.2018.06.006. Epub 2018 Jul 13.
10
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor.绝对嗜碱性粒细胞计数与接受经尿道膀胱肿瘤切除术 (TURBT) 后卡介苗灌注治疗的高级别 T1 膀胱癌患者复发时间相关。
World J Urol. 2020 Jan;38(1):143-150. doi: 10.1007/s00345-019-02754-2. Epub 2019 Apr 16.